ArticleHead & neck2014

Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck.

Vittal V S Kurisetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.